Brett Winton

Chief Executive Officer

Brett Winton is a globally recognized innovation strategist, futurist, and technology executive with extensive experience leading disruptive innovation across artificial intelligence, robotics, healthcare, and emerging technologies. He has spent more than a decade researching transformative industries, identifying breakthrough technologies, and guiding long-term strategic investments that shape the future of global healthcare.

As Chief Executive Officer of NeuroMotion Medical Biotechnology, Brett leads the company's global vision, corporate strategy, product innovation, and commercialization initiatives. He is responsible for accelerating the development of AI-powered medical robotics, intelligent exoskeleton systems, and next-generation rehabilitation technologies designed to improve patient mobility and clinical outcomes.

Working closely with the company's executive leadership, engineering, and clinical teams, Brett drives innovation by integrating artificial intelligence, advanced robotics, data intelligence, and precision medicine into scalable healthcare solutions. His leadership focuses on building strategic partnerships, expanding global market presence, and positioning NeuroMotion as a leader in intelligent rehabilitation and digital healthcare technologies.